CareDx, Inc. is a company in the U.S. stock market and it is a holding in 33 U.S.-traded ETFs. CDNA has around 4.6M shares in the U.S. ETF market. The largest ETF holder of CDNA is the SPDR S&P Biotech ETF (XBI), with approximately 1.98M shares. Investors may also find of interest that the ETF with the largest allocation to CDNA stock is ARK Genomic Revolution ETF (ARKG), with a portfolio weight of 2.26%. On average, U.S. ETFs allocate 0.17% of CDNA to their portfolios.
Additionally, CDNA is a favorite stock for Vanilla and Fundamental ETFs. It is also most likely to belong to Broad-based ETFs. The best-performing ETF in the past 12 months with CDNA as a holding is the Principal Healthcare Innovators Index ETF (BTEC), with a return of 17.23%.